|
VALE® Technology
All other transdermal technologies combined can only deliver about 12-15 drugs transdermally (these are drugs like nicotine, testosterone, estrogen, fentanyl, etc. which have a rare molecular structure). Only VALE® technology has demonstrated that it can work with the majority of the pharmacopoeia.
Topically applied,
VALE® products currently under development are intended to offer
an effective method to quickly and safely deliver a wide variety
of active drug molecules deep into the skin tissue or the blood stream.
Delivering a drug through the skin rather than orally is potentially
safer as it avoids gastro-intestinal problems, first pass liver effect,
and interaction with other oral drugs. Additionally, transdermal
delivery can target specific areas directly with small doses of a
drug avoiding the need to deliver massive oral doses, which create
additional side effects.
With the launch of
VALE® products, BioChemics hopes to provide a significant technological
advance in the field of transdermal drug delivery.
|